paclitaxel has been researched along with Papillomavirus Infections in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 14 (56.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koo, P; Malin, M; Okereke, J | 1 |
| Agrawal, N; Blair, E; Cipriani, N; Edelstein, DL; Fredebohm, J; Ginat, D; Gooi, Z; Haraf, D; Holtrup, F; Izumchenko, E; Jones, FS; Juloori, A; Karrison, T; Keyser, K; Lingen, M; Pearson, A; Rosenberg, AJ; Sloane, H; Vokes, EE | 1 |
| Demes, M; Eichler, K; Jeroch, J; Martin, D; Pession, U; Schulze, F; Waidmann, O; Wild, P | 1 |
| Ikemura, M; Komura, A; Miyamoto, Y; Mori, M; Nishijima, A; Oda, K; Osuga, Y; Sone, K; Taguchi, A; Tanikawa, M | 1 |
| Amjad, ZS; Babaei, F; Bayat, M; Doroudian, M; Haghighi, ZMS; Karampour, R; Moghoofei, M; Nahand, JS; Payandeh, M; Rafigh, M; Roozgari, M; Tabatabaei, T | 1 |
| Adkins, DR; Daly, M; Gay, HA; Jackson, R; Johnson, KCC; Ley, J; Lu, J; Oppelt, P; Paniello, RC; Pipkorn, P; Rich, J; Thorstad, W; Zevallos, J | 1 |
| Belille, E; Brenner, JC; Carey, TE; Goudsmit, CM; Marchiano, E; McHugh, JB; Shuman, AG; Spector, ME; VanKoevering, KK; Walline, HM | 1 |
| Dunn, LA; Fury, MG; Haque, SS; Ho, AA; Katabi, N; Pfister, DG; Sherman, EJ | 1 |
| Agrawal, N; Blair, EA; Brisson, RJ; Dekker, A; Foster, CC; Ginat, DT; Gooi, Z; Haraf, DJ; Karrison, TG; Kochanny, S; Lingen, MW; Melotek, JM; Portugal, L; Seiwert, TY; Villaflor, VM; Vokes, EE | 1 |
| Blumenschein, GR; Garden, AS; Ginsberg, LE; Glisson, BS; Gold, KA; Haddad, RI; Hutcheson, K; Johnson, FM; Kies, MS; Lee, JJ; Lewis, J; Lin, HY; Massarelli, E; Myers, J; Papadimitrakopoulou, V; Pharaon, RR; Pickering, C; Rabinowits, G; Tishler, RB; William, WN; Williams, MD | 1 |
| Killock, D | 1 |
| Domingos-Pereira, S; Galliverti, G; Hanahan, D; Nardelli-Haefliger, D | 1 |
| Chen, Y; Chen, Z; Ma, C; Ma, L; Zhang, W | 1 |
| Chang, TC; Chao, A; Chen, MY; Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Lin, G; Lin, H; Liou, JD; Liou, YL; Liu, FY; Yang, LY | 1 |
| Arnold, SM; Brill, Y; Dressler, EV; Gleason, JF; Kudrimoti, M; Silver, NL; Valentino, J | 1 |
| Arya, S; Bhattacharjee, A; D'Cruz, A; Dhumal, S; Joshi, A; Juvekar, S; Kane, S; Muddu, V; Noronha, V; Patil, VM; Prabhash, K | 1 |
| Chen, ZG; Majumdar, D; Rahman, MA; Shin, DM | 1 |
| Menolasino, MJ; Shaw, BL | 1 |
| Bae, JH; Ho, EM; Park, JS; Tong, SY; Um, SJ; Yim, EK | 1 |
| Annino, DJ; Balboni, TA; Goguen, LA; Haddad, RI; Lorch, J; Norris, CM; Posner, MR; Sher, DJ; Thotakura, V; Tishler, RB | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Engblom, P; Grénman, S; Haarala, M; Hietanen, S; Raitanen, M; Rantanen, V; Syrjänen, S | 1 |
| Chávez-Blanco, A; Dueñas-González, A; García-López, P; González-Fierro, A; Lizano-Soberon, M; Mariscal, I; Pérez-Cárdenas, E; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Treviño-Cuevas, H; Wegman-Ostrosky, T | 1 |
| Gercel-Taylor, C; Saxena, A; Taylor, DD; Yashar, C | 1 |
| Cmelak, A; Fakhry, C; Forastiere, A; Gillison, ML; Li, S; Pinto, H; Ridge, JA; Westra, WH | 1 |
6 trial(s) available for paclitaxel and Papillomavirus Infections
| Article | Year |
|---|---|
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cell-Free Nucleic Acids; Chemoradiotherapy; Cisplatin; DNA, Viral; Drug Monitoring; Feasibility Studies; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Prospective Studies; Treatment Outcome; Young Adult | 2022 |
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.
Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin | 2018 |
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Survival Rate | 2019 |
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Squamous Cell Carcinoma of Head and Neck | 2019 |
Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Human papillomavirus 16; Humans; Hysterectomy; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiotherapy, Adjuvant; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Paclitaxel; Papillomavirus Infections; Polymerase Chain Reaction; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Treatment Outcome | 2008 |
19 other study(ies) available for paclitaxel and Papillomavirus Infections
| Article | Year |
|---|---|
A 31-Year-Old Pregnant Woman With Asthma, Presenting With Worsening Dyspnea, Wheeze, and Hoarseness.
Topics: Adult; Antineoplastic Agents; Asthma; Carboplatin; Cesarean Section; Cyclin-Dependent Kinase Inhibitor p16; Deglutition Disorders; Diagnosis, Differential; Female; Hoarseness; Humans; Laryngeal Neoplasms; Laryngoscopy; Paclitaxel; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and
Topics: Anus Neoplasms; Carboplatin; HIV Infections; Humans; Microsatellite Instability; Mutation; MutL Protein Homolog 1; Nivolumab; Paclitaxel; Papillomavirus Infections; Programmed Cell Death 1 Receptor | 2022 |
A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab.
Topics: Adult; Carboplatin; Carcinoma, Squamous Cell; Female; Humans; Neoplasms, Unknown Primary; Nivolumab; Paclitaxel; Papillomavirus Infections; Prognosis | 2023 |
Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer.
Topics: Breast Neoplasms; Caspase 3; Cytochromes c; Drug Resistance, Neoplasm; Female; Human Papillomavirus Viruses; Humans; Oncogene Proteins, Viral; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2023 |
nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Female; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Papillomavirus Infections; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
An Algorithm to Evaluate Suspected Lung Metastases in Patients with HPV-Associated Oropharyngeal Cancer.
Topics: Algorithms; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Diagnosis, Differential; Female; Human papillomavirus 16; Humans; Immunohistochemistry; In Situ Hybridization; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Paclitaxel; Papillomavirus Infections; Precision Medicine; Prospective Studies | 2018 |
Towards risk-stratified induction regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Paclitaxel; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome | 2019 |
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors.
Topics: Administration, Intravaginal; Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Combined Modality Therapy; Disease Models, Animal; Female; Genital Neoplasms, Female; Human papillomavirus 16; Humans; Immunotherapy; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Oligodeoxyribonucleotides; Paclitaxel; Papillomavirus E7 Proteins; Papillomavirus Infections; Toll-Like Receptor 9; Vaccines, Synthetic; Vagina | 2019 |
Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Chi-Square Distribution; China; DNA, Viral; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genotype; Human papillomavirus 16; Human Papillomavirus DNA Tests; Humans; Lymphatic Metastasis; MicroRNAs; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Papillomavirus Infections; Real-Time Polymerase Chain Reaction; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2014 |
p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer.
Topics: Adult; Antineoplastic Agents; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Gene Expression Profiling; Genes, p16; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomavirus Infections; Remission Induction; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome | 2015 |
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Survival Rate; Taxoids; Young Adult | 2015 |
Anticancer activity of drug conjugates in head and neck cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cysteine; Esters; Head and Neck Neoplasms; Humans; Hydrogen-Ion Concentration; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Papillomavirus Infections; Sexually Transmitted Diseases | 2016 |
Metastatic penile squamous cell carcinoma to the retroperitoneum in a man with human papillomavirus type 45.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Humans; Male; Middle Aged; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Retroperitoneal Neoplasms; Retroperitoneal Space | 2008 |
Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression; HeLa Cells; Human papillomavirus 18; Humans; Microtubule-Associated Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Papillomavirus Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Uterine Cervical Neoplasms | 2009 |
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Panitumumab; Papillomavirus Infections; Proportional Hazards Models; Radiation Tolerance; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids; Treatment Failure | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Mutations of TP53 do not correlate with the sensitivity to paclitaxel--a study using 27 gynaecological cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Female; Genes, p53; Genital Neoplasms, Female; Humans; Inhibitory Concentration 50; Mutation; Paclitaxel; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Tumor Cells, Cultured; Tumor Virus Infections | 2002 |
Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; DNA, Neoplasm; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Gemcitabine; HeLa Cells; Humans; In Vitro Techniques; Mice; Mice, Nude; Middle Aged; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Nucleosomes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Rats; Rats, Wistar; Tumor Virus Infections; Uterine Cervical Neoplasms | 2003 |
Cellular response to chemotherapy and radiation in cervical cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Survivin; Uterine Cervical Neoplasms | 2005 |